BioMark Diagnostics Inc.
BUX
Classement en actions
#26637
BioMark Diagnostics Inc. is an oncology specialist, developing advanced... BioMark Diagnostics Inc. is an oncology specialist, developing advanced diagnostic tools for cancer to enable early detection, continuous patient monitoring, and the assessment of initial treatment efficacy. The firm holds a research partnership with the Icahn School of Medicine, collaborating on clinical trials specifically addressing the early identification of lung cancer. Founded in 2014, its corporate headquarters are situated in Richmond, Canada. BioMark Diagnostics Inc. operates as a subsidiary of Biomark Technologies Inc.
Prix de l'action
$0.33433516
Dernière synchronisation: 2026-10-20
Capitalisation boursière
$35.60M
Changement (1 jour)
-3.08%
Changement (1 an)
39.31%
Pays
CA
Échange BioMark Diagnostics Inc. (BUX)
Catégorie
Healthcare
Historique du prix de l'action pour BioMark Diagnostics Inc. (BUX)
Prix de clôture le plus élevé : $0.38 le 2026-10-01
Prix de clôture le plus bas : $0.35 le 2015-03-01
Prix de clôture le plus bas : $0.35 le 2015-03-01
Historique du prix de l'action de BioMark Diagnostics Inc. de 2015 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2026 (TTM) | 6.88% |
| 2025 | 136.71% |
| 2024 | -19.87% |
| 2023 | 29.58% |
| 2022 | -34.72% |
| 2021 | 122.09% |
| 2020 | -51.07% |
| 2019 | 376.19% |
| 2018 | -44.93% |
| 2017 | -9.77% |
| 2016 | -22.98% |
| 2015 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $21.22 | 49.87% |
CN
|
|
| $177.93 | 21.98% |
US
|
